Antiviral activity of highly potent siRNAs against echovirus 30 and its receptor

J Virol Methods. 2009 May;157(2):211-8. doi: 10.1016/j.jviromet.2009.01.012. Epub 2009 Jan 31.

Abstract

RNA interference (RNAi) has been shown to be suitable to inhibit viruses in experimental setups and is considered a promising antiviral strategy that is currently being tested in various clinical trials. The present study provides an approach to design siRNAs with high potency against a virus-specific target gene. In recent years, several outbreaks of aseptic meningitis caused by an echovirus 30 (EV-30) infection have been described. Based on an initial set of 30 in silico designed siRNAs, six siRNAs targeting the 3D RNA-dependent RNA-Polymerase (3D(Pol)) of EV-30 were selected. All but one of them showed high efficiency in both, reporter and virus assays. A second aim of the study was to re-investigate the relevance of the decay-accelerating factor (DAF, also known as CD55) as cellular entry receptor of EV-30 by means of RNAi, a question which had been under debate in previous studies. Knockdown of DAF inhibited drastically infection by EV-30 indicating that DAF plays an important role either as an attachment factor or as a receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology*
  • Cell Line
  • Enterovirus B, Human / drug effects*
  • Enterovirus B, Human / genetics
  • Gene Knockdown Techniques
  • Humans
  • RNA Interference
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / pharmacology*
  • RNA-Dependent RNA Polymerase / antagonists & inhibitors
  • Receptors, Virus / antagonists & inhibitors*
  • Receptors, Virus / genetics
  • Viral Proteins / antagonists & inhibitors

Substances

  • Antiviral Agents
  • RNA, Small Interfering
  • Receptors, Virus
  • Viral Proteins
  • RNA-Dependent RNA Polymerase